ArticleScientific reports2014

A designed peptide targeting CXCR4 displays anti-acute myelocytic leukemia activity in vitro and in vivo.

Xiaojin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.